SWEAT fluctuated by 40.1% in 24 hours: driven by low liquidity, with no clear catalyst event
Bitget Pulse2026/05/22 20:18Volatility Brief
In the past 24 hours (May 21—22, 2026), SWEAT experienced significant price fluctuations, surging from a low of $0.0009481 to a high of $0.001328. The current price has recovered to $0.0012229, resulting in an amplitude of 40.1%.
Certain data sources show that the 24-hour trading volume during the same period was approximately $1.5 million to $3.7 million, with a market capitalization remaining at a low of around $12 million, characteristic of typical low liquidity, small-cap assets.
Brief Analysis of the Cause of Abnormal Movement
Through public market searches and real-time discussions on X, no major official announcements, large on-chain transfers, whale activities, or direct mainstream media news regarding SWEAT were found to have directly triggered this volatility within the past 24 hours.
A short-term trend focus occurred previously on May 10—11 (linked to utility assets such as SUI, ZANO, etc.), but this has exceeded the 24-hour effective window and is not considered a driving factor for the current movement.
This incident mainly reflects the high Beta volatility commonly seen in low market cap tokens, with no verifiable single leading event at this time.
Market Views and Outlook
There is low discussion heat within the community and on major platforms, with no significant sentiment divergence or consensus forecasts. Some price prediction models indicate that SWEAT may maintain a narrow range or a slight downward adjustment in the short term (for example, the May 22—23 interval is forecasted at around $0.0012—$0.0014).
In a low liquidity environment, prices are easily influenced by overall market sentiment or sporadic trades. It is advised to monitor subsequent on-chain data and official updates to assess the sustainability of the movement.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
A Major Reversal Amid the U.S. Bond Selloff! Bond Market Veteran Bianco Turns Bullish for the First Time in Six Years, Calling 5% Yield a "Value Buy Opportunity"
Currently, as benchmark U.S. Treasury yields surge to their highest levels in nearly two decades, bond market veteran Jim Bianco has loosened his bearish stance for the first time and is gradually building long positions as a "value buyer."
Crypto prices
More
